Portuguese, A., Davis, J., Raza, S., Puglianini, O. A. C., Freeman, C. L., Alsina, M., Wright, C., Goel, U., Khouri, J., Anwer, F., Ali, H. M., Pasvolsky, O., Gaballa, M., Patel, K., Pleitez, H. G., Mikulski, D., Fogel, L., Zolotov, E., Sannareddy, A., Afrough, A., Anderson, L., Julian, K., Dima, D., Banerjee, R., Liang, E., Cassano, R. C., Herr, M., Hassan, H., Shune, L., Kort, J., Midha, S., Nadeem, O., Sidana, S., Lin, Y., Locke, F., Hansen, D., Sborov, D., Biran, N., Grajales-Cruz, A. (2025). Real-world outcomes with elranatamab in multiple myeloma: A multi-center analysis from the United States multiple myeloma immunotherapy consortium. Blood. https://doi.org/10.1182/blood-2025-136